NASDAQ:NRIX | Free Cash Flow | Nurix Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-11-30 to 2026-02-28
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-02-28-$71.91M$1.05M-$72.96M
2025-11-30-$67.83M$5.13M-$72.96M
2025-02-28-$61.09M$3.49M-$64.57M
2024-11-30-$48.75M$2.11M-$50.86M
2024-02-29-$41.95M$2.88M-$44.84M
2023-11-30$26.69M$2.59M$24.1M
2023-02-28-$48.45M$2.28M-$50.73M
2022-11-30-$37.96M$2.57M-$40.52M
2022-02-28-$42.63M$3.47M-$46.1M
2021-11-30-$30.91M$862,000.00-$31.77M
2021-02-28$8.05M$843,000.00$7.21M
2020-11-30-$20.48M$906,000.00-$21.39M
2020-02-29$40.97M$364,000.00$40.61M
2019-11-30-$12.75M$953,000.00-$13.7M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-11-30-$249.47M$14M-$263.47M
2024-11-30-$172.58M$9.27M-$181.86M
2023-11-30-$81.37M$8.4M-$89.77M
2022-11-30-$159.81M$12.24M-$172.05M
2021-11-30-$84.37M$5.66M-$90.03M
2020-11-30-$80,000.00$4.55M-$4.63M
2019-11-30$601,000.00$1.65M-$1.05M